Phone : +91-22-2207 0099 Email : info@ottokemi.com, sales@ottokemi.com
2-[3-(1-Carboxy-5-{3-naphthalen-2-yl-2-[(4-{[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraaza-cyclododec-1-yl)-acetylamino]-methyl}-cyclohexanecarbonyl)-amino]-propionylamino}-pentyl)-ureido]-pentanedioic acid, PSMA617 TFA; PSMA617 triflouroacetic acid salt; vipivotide tetraxetan; DKFZ-PSMa-617
PS 0090
puriss
C49H71N9O16.CF3COOH
29420090
18%
1702967-37-0
95%+
1042.14 (net)
Vial / Bottle
PS 0090 (OTTO) PSMA 617 Cas 1702967-37-0 - used in chemical research.
PSMA-617 - a novel theranostic PSMA inhibitor for both diagnosis and endoradiotherapy of prostate cancer.
Cell biology, Cancer research
Powder
Colourless to white to off-white
1041.5
-20 °C
Safety Information for this product is unavailable at this time.
DisclaimerThe above particulars do not release the customer from the obligation to carry out an inspection of goods received. For laboratory use only. Not for drug, medical, household, or any other unauthorized application. We assume no liability for misuse or unauthorized application of the product. Please test before use.